Sam Chen

Sam Chen is a scientist who currently works in product development at Dyno Therapeutics. Sam has also worked as an intern at Genentech, where they developed an in-house R package, Epiregulon, that infers transcription factor activity by integrating scRNA-seq and scATAC-seq data. Sam has also worked as a Ph.D. candidate at Northwestern University - The Feinberg School of Medicine, where they worked on in silico benchmarking and comparison between different RNA-seq library preparation protocols.

Dr. Sam Chen completed a Bachelor of Science in Biochemistry from Stony Brook University. Sam then went on to earn a Doctor of Philosophy in Computational Biology from Northwestern University - The Feinberg School of Medicine. In addition, they have completed a Management for Scientists and Engineers Certificate from Northwestern University - Kellogg School of Management.